Altimmune, Inc. (ALT): Total Liabilities
$55.04M
As of 2025-12-31
$53.00M
As of 2026-06-30
+36.5%
3-year compound annual growth
+23.4%
5-year compound annual growth
+32.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $55.04M | +248.4% | 2026-03-06, Balance as of period end |
| 2024-12-31 | $15.80M | -4.5% | 2026-03-06, Balance as of period end |
| 2023-12-31 | $16.54M | -23.5% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $21.64M | +9.7% | 2024-03-27, Balance as of period end |
| 2021-12-31 | $19.73M | +2.6% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $19.24M | +125.3% | 2022-03-15, Balance as of period end |
| 2019-12-31 | $8.54M | +32.6% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $6.44M | -55.1% | 2020-03-27, Balance as of period end |
| 2017-12-31 | $14.35M | +131.8% | 2019-04-01, Balance as of period end |
| 2016-12-31 | $6.19M | +92.7% | 2018-04-02, Balance as of period end |
| 2015-12-31 | $3.21M | -13.3% | 2017-03-14, Balance as of period end |
| 2014-12-31 | $3.70M | -62.2% | 2016-03-11, Balance as of period end |
| 2013-12-31 | $9.80M | -11.4% | 2015-03-11, Balance as of period end |
| 2012-12-31 | $11.07M | +59.2% | 2014-03-11, Balance as of period end |
| 2011-12-31 | $6.95M | -53.6% | 2013-03-14, Balance as of period end |
| 2010-12-31 | $14.99M | n/a | 2012-03-08, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Altimmune, Inc. (ALT) | 2025-12-31 | $55.04M | +248.4% |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | $20.33M | +127.9% |
| Lyell Immunopharma, Inc. (LYEL) | 2025-12-31 | $91.85M | -15.0% |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | $1.85M | -85.8% |
| HCW Biologics Inc. (HCWB) | 2025-12-31 | $21.76M | -41.2% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| Talphera, Inc. (TLPH) | 2025-12-31 | $12.68M | +23.9% |
| Connect Biopharma Holdings Ltd (CNTB) | 2025-12-31 | $14.10M | +54.6% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $50.21M | +12.4% |
Compare ALT, NTHI, LYEL, IBO side by side · Screen every company in Pharmaceutical Preparations ↗